Comprehensive DMD testing
NGS panel analyzing 133 neuromuscular genes to evaluate muscular dystrophies and myopathies (e.g., DMD, RYR1, TTN, LMNA, LAMA2, COL6A1-3, CAPN3, DYSF).
Accessed through the Decode Duchenne Sponsored Testing Program•Sponsored by Sarepta Therapeutics, Parent Project Muscular Dystrophy•Performed by Revvity Omics, Inc.
Designed to support clinical decision-making and ordering in your practice.
For healthcare providers
Overview
Decode Duchenne provides sponsored, no-cost diagnostic testing for suspected Duchenne/Becker muscular dystrophy in patients residing in the U.S. or Canada. The program is administered with Parent Project Muscular Dystrophy and performed by Revvity Omics; industry partners (e.g., Sarepta and others) provide support. Order per clinical presentation; genetic counseling resources are available.
When to consider this test
Patient selection
- Known or suspected Duchenne/Becker muscular dystrophy, or elevated CK consistent with DMD/BMD evaluation.
- If ordering due to positive family history, contact Decode Duchenne (888-520-8675 option 1; [email protected] to confirm the appropriate test—payment may not be provided for incorrectly ordered tests.
- Not intended for carrier testing; use the carrier-testing workflow.
Workflow
How to use this program
- 1
Select & order
Order diagnostic testing for suspected/known DMD/BMD or elevated CK; complete requisition and consent. For family-history–driven testing, contact Decode Duchenne to confirm the appropriate test.
- 2
Collect & ship
Collect blood/saliva/DBS; label with patient name and DOB. Include clinical notes, package with requisition/consent, and ship per kit or specimen guidelines.
- 3
Review results
Expect results in ~14–21 days via Revvity Omics. Review with the patient and consult Decode Duchenne genetic counselors as needed.
Billing overview
Program billing
For eligible patients, the sponsor has arrangements with the laboratory that may reduce or cover some or all of the patient's out-of-pocket cost. Actual cost and patient responsibility vary by program criteria. Refer to lab or sponsor materials for details.
Quality & privacy
Laboratory quality & data handling
Testing is performed by Revvity Omics, Inc., a CLIA-certified laboratory (CLIA 39D0673919). Your sample is processed using validated methods and quality controls to support reliable genetic results.
Your health information is handled under privacy and security practices that are intended to align with applicable regulations. For program- and lab-specific details, review the privacy information provided by the laboratory and sponsor.
FAQ
Frequently asked questions
When should I order?
For suspected or confirmed DMD/BMD, or unexplained hyperCKemia consistent with DMD/BMD evaluation.
What about family-history–driven testing?
Contact the Decode Duchenne team before ordering to ensure the correct test; payment may not be provided for misordered tests.
Which specimens are accepted?
Whole blood, saliva, or DBS per kit/specimen guidelines; include complete requisition, consent, and pertinent clinical notes.
Typical turnaround time?
Approximately 14–21 days from specimen receipt.
Is carrier testing included?
No. Use the program’s carrier-testing channel or your standard carrier workflow.
Are genetic counselors available?
Yes—program genetic counselors are available for ordering support and post-result questions.
How are results reported?
Reports are delivered to the ordering clinician with variant interpretation per lab policy.
Geographic scope?
Eligible patients in the U.S. and Canada.
See an issue with this program?